Science Translational MedicineIntegrating Medicine and Science
1st Issue Published 7 October 2009
Mission statement | Purpose | Editors | Audience | Scope | Translational Medicine Defined | Content | Issue Elements | Translational Medicine Editorials | Press Releases and Announcements | Call for Papers | Information for Contributors | Subscription | Title Abbreviation | Advertising | Key Preliminary Dates | Download Poster | Contact Information
This video describes Science Translational Medicine, the newest journal from Science. The video features interviews with Katrina Kelner, Editor; Elias Zerhouni, Chief Scientific Adviser; Bruce Alberts, Editor-in-Chief of Science; and Alan Leshner, AAAS CEO and Executive Publisher, Science.
Please download the latest version of the free Flash plug-in.
Mission statement: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.
Purpose: A profound transition is required for the science of translational medicine. Despite 50 years of advances in our fundamental understanding of human biology and the emergence of powerful new technologies, the rapid transformation of this knowledge into effective health measures continues to elude biomedical scientists. This paradox illustrates the daunting complexity of the challenges faced by translational researchers as they apply the basic discoveries and experimental approaches of modern science to the alleviation of human disease. Studies in humans often highlight deep gaps in our fundamental understanding of biology, but the linkages back to basic research to fill these gaps have not been as effective as they could be. Clearly, creative experimental approaches, novel technologies and new ways of conducting scientific explorations at the interface of established and emerging disciplines are now required to an unprecedented degree if real progress is to be made. Nothing short of a true reinvention of the science of translational medicine is likely to suffice. To aid in this reinvention, Science and AAAS have created a new interdisciplinary journal, Science Translational Medicine.
Chief Scientific Adviser
For a complete list of Advisory Board Members please click here [PDF].
Audience: Researchers and management in academia, government, and the biotechnology and pharmaceutical industries; physician scientists; regulators; policy makers; investors; business developers; and funding agencies.
Scope: Cancer, cardiovascular disease, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, immunology/vaccines, infectious diseases, policy, behavior, bioengineering, physics, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, other interdisciplinary approaches to medicine.
Translational medicine defined: Often described as an effort to carry scientific knowledge "from bench to bedside," translational medicine builds on basic research advances - studies of biological processes using cell cultures, for example, or animal models - and uses them to develop new therapies or medical procedures. Click here for more details.
Content: The editors and an international advisory group of clinician scientists and other experts will hold these articles to the same high-quality standard that is the hallmark of the journal Science.
Future content: Meeting Reports, Teaching Resources
"Drugs, Industry, and Academia," Science, June 20, 2008: Garrett A. FitzGerald, Director of the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania, cites initiatives such as the Medicines for Malaria Venture and the TB Alliance as he examines issues faced by government and industry as translational medicine moves into the debate of treating disease and finding cures.
"Translational medicine: science or wishful thinking?" Journal of Translational Medicine, June 17, 2008: Martin Wehling describes "Translational medicine" as a fashionable term that is being increasingly used to describe the wish of biomedical researchers to ultimately help patients. It is therefore claimed that a new science needs to be developed called "translational science in medicine."
© 2008 Wehling; licensee BioMed Central Ltd.
Press releases and announcements: Elias Zerhouni, M.D., former Director of the National Institutes of Health, has been named Chief Scientific Adviser of Science Translational Medicine.
Call for papers: The editors are now accepting submissions for review. Click here for the editor's call for papers.
Information for contributors: Please review these instructions and information before submitting your manuscripts.
Three-Year Institutional Sitewide Subscription Pricing and Agreement
Terms and Agreement
To qualify for this special three-year offer Licensee must:
Please click here to download the baby genius Science Translational Medicine poster.